Yatırımcı.AI

CLEBI vs ECILC Comparison

Price, market cap, valuation, profitability and leverage metrics of CLEBI and ECILC side by side.

CLEBIECILC
StockFund

If You Had Invested TRY 10,000

Metric Comparison

CLEBI vs ECILC Comparison
MetricCLEBIECILCSector median
Last price (TL)1,349.0064.7026.26
Daily change−0.59%1.33%−2.51%
Market capTRY 32.8BTRY 44.3BTRY 7.2B
P/E9.60—10.04
P/B4.700.641.21
Dividend yield5.11%2.04%0.65%
Return on equity46.07%−3.08%6.37%
Free float10.05%22.02%27.92%
Ratios are calculated from the latest published financial statements.

Popular Comparisons

Related Pages

About the CLEBI vs ECILC Comparison

Price, market cap, valuation multiples, profitability and leverage of CLEBI (Celebi) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 29, 2026, 15:37. Of the 16 metrics compared, CLEBI leads in 9 and ECILC leads in 7.

Highlights: Daily change: ECILC leads (1.33% vs −0.59%). Market cap: ECILC leads (TRY 44.3B vs TRY 32.8B). P/B: ECILC leads (0.64 vs 4.70). EV/EBITDA: CLEBI leads (6.75 vs 154.32). EV/Sales: CLEBI leads (3.78 vs 8.73). Dividend yield: CLEBI leads (5.11% vs 2.04%). Gross margin: ECILC leads (37.83% vs 29.16%). EBITDA margin (annual): CLEBI leads (27.86% vs 11.49%).

Frequently Asked Questions

By P/E, Tie is cheaper (9.60 vs —); by P/B, ECILC trades at the lower multiple (4.70 vs 0.64).

Annual net margin is 16.41% for CLEBI and −20.86% for ECILC; return on equity is 46.07% for CLEBI and −3.08% for ECILC.

The leverage ratio is 65.70 for CLEBI and 18.92 for ECILC; net debt/EBITDA is 1.10 for CLEBI and 1.37 for ECILC. Lower values mean less leverage.

Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.